Live Ventures Subsidiary, Vintage Stock, Inc., Opens Eight New Stores
Jan 31, 2017 13:31 pm UTC| Business
LAS VEGAS, Jan. 31, 2017 -- Live Ventures Incorporated, (Nasdaq:LIVE), (the “Company”), a diversified holding company, today announces its subsidiary, Vintage Stock, Inc., America’s entertainment superstore chain, has...
Amyris to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Thursday, March 2, 2017
Jan 31, 2017 13:31 pm UTC| Business
EMERYVILLE, Calif., Jan. 31, 2017 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2016 after market close on Thursday, March 2, 2017. The...
Amyris to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Thursday, March 2, 2017
Jan 31, 2017 13:31 pm UTC| Business
EMERYVILLE, Calif., Jan. 31, 2017 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2016 after market close on Thursday, March 2, 2017. The...
Skkynet to Exhibit New IIoT Technology at ARC Industry Forum
Jan 31, 2017 13:30 pm UTC| Business
Mississauga, Ontario, Jan. 31, 2017 -- Skkynet Cloud Systems, Inc. (“Skkynet”) (OTCQB: SKKY), a global leader in real-time cloud information systems, will demonstrate the latest release candidate of the Cogent DataHub®...
Jan 31, 2017 13:30 pm UTC| Business
MADISON, Wis., Jan. 31, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the advance online publication of an article in...
Apple Co-Founder Steve “The Woz” Wozniak to Speak at Coupa Inspire 2017
Jan 31, 2017 13:30 pm UTC| Business
SAN MATEO, Calif., Jan. 31, 2017 -- Coupa Software (NASDAQ:COUP), a leader in cloud-based spend management, today announced that Apple Co-Founder Steve Wozniak will be the distinguished speaker at Coupa Inspire ’17,...
Jan 31, 2017 13:30 pm UTC| Business
MENLO PARK, Calif., Jan. 31, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...